- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
- IMMUPHARMA AT BIO-EUROPE SPRING 2024
- Financial, Business and Portfolio Develop't Update
- Holding(s) in Company
- Simbec-Orion appointed as CRO
- Incanthera - Comm'l Skincare Deal/£1M Fundraise
- Result of Retail Offer and Director Shareholding
More ▼
Key statistics
On Friday, ImmuPharma PLC (IMM:LSE) closed at 2.35, -38.16% below its 52-week high of 3.80, set on Jun 19, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.20 |
---|---|
High | 2.30 |
Low | 2.20 |
Bid | 2.26 |
Offer | 2.40 |
Previous close | 2.24 |
Average volume | 1.26m |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 9.33m GBP |
EPS (TTM) | -0.0092 GBP |
Data delayed at least 20 minutes, as of Apr 19 2024 16:05 BST.
More ▼